Posts from January 2017

Other highlights include industry recognition for leadership in NLP healthcare solutions

Cambridge, UK & Boston, USA – January 25th, 2017 –Text analytics provider Linguamatics today announced that 2016 represented one of the company’s most successful years ever, further positioning the organization as the leading provider of Natural Language Processing (NLP) text mining solutions for healthcare and the life sciences. Highlights from the past year include the highly-anticipated I2E 5.0 release; the addition of further high-profile customers and strategic partners; and industry recognition from leading research firms KLAS, Forrester and Frost & Sullivan.

Read more

I am pleased to announce that the Linguamatics Community is now open for registration for all Linguamatics I2E users.

Peer-to-peer support and networking forum - discuss the software, as well as share queries and scripts.

Share I2E best practices - through forums, articles, blogs, videos, and presentations. You can find over a hundred Hints and Tips posts, how-to video tutorials, and customer case studies.

https://community.linguamatics.com/

Download Linguamatics software, resources and technical documentation - content previously accessed on I2Edia and the Download Site is being migrated to the Community, so your login gives access to everything you need from Linguamatics.

SIGN UP NOW

Read more

At the end of 2016, I attended the CBI 2nd Annual IDMP Update Forum in Philadelphia, a small but highly focused and effective conference with two days of meetings and discussions. There were presentations by industry leaders involved in understanding and addressing the challenges that IDMP compliance presents to the pharmaceutical industry, and also presentations by some of the vendors in this area.

The meeting kicked off with a keynote from John Kiser, Senior Director, Regulatory Policy and Intelligence, AbbVie.  This brought up some of the key challenges for IDMP compliance that were repeated again and again across the conference:

  • We need to think strategically, about master data management (MDM), not just about what is needed for IDMP compliance.
  • Even though the timelines are moving out, it’s really important not to take our eye off the ball. IDMP projects are being driven out of EU, and the US has to get moving to keep up. Don’t wait, start planning and kicking off pilots and proof-of-concepts with vendors now.
  • IDMP compliance planning shouldn’t just involve regulatory affairs and supply chain departments, as IDMP will impact quality, clinical operations, pharmacovigilance and safety, production, IT and more.

How text analytics using I2E can help

One comment that interested me was that while manual curation may provide the data elements for the current understanding of Iteration 1, other strategies will be needed to deal with potential changes in the implementation guidance, and to accommodate the flexibility required for Iteration 2 and beyond.

Read more